Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
mTOR–neuropeptide Y signaling sensitizes nociceptors to drive neuropathic pain
Lunhao Chen, Yaling Hu, Siyuan Wang, Kelei Cao, Weihao Mai, Weilin Sha, Huan Ma, Ling-Hui Zeng, Zhen-Zhong Xu, Yong-Jing Gao, Shumin Duan, Yue Wang, Zhihua Gao
Lunhao Chen, Yaling Hu, Siyuan Wang, Kelei Cao, Weihao Mai, Weilin Sha, Huan Ma, Ling-Hui Zeng, Zhen-Zhong Xu, Yong-Jing Gao, Shumin Duan, Yue Wang, Zhihua Gao
View: Text | PDF
Research Article Neuroscience

mTOR–neuropeptide Y signaling sensitizes nociceptors to drive neuropathic pain

  • Text
  • PDF
Abstract

Neuropathic pain is a refractory condition that involves de novo protein synthesis in the nociceptive pathway. The mTOR is a master regulator of protein translation; however, mechanisms underlying its role in neuropathic pain remain elusive. Using the spared nerve injury–induced neuropathic pain model, we found that mTOR was preferentially activated in large-diameter dorsal root ganglion (DRG) neurons and spinal microglia. However, selective ablation of mTOR in DRG neurons, rather than microglia, alleviated acute neuropathic pain in mice. We show that injury-induced mTOR activation promoted the transcriptional induction of neuropeptide Y (Npy), likely via signal transducer and activator of transcription 3 phosphorylation. NPY further acted primarily on Y2 receptors (Y2R) to enhance neuronal excitability. Peripheral replenishment of NPY reversed pain alleviation upon mTOR removal, whereas Y2R antagonists prevented pain restoration. Our findings reveal an unexpected link between mTOR and NPY/Y2R in promoting nociceptor sensitization and neuropathic pain.

Authors

Lunhao Chen, Yaling Hu, Siyuan Wang, Kelei Cao, Weihao Mai, Weilin Sha, Huan Ma, Ling-Hui Zeng, Zhen-Zhong Xu, Yong-Jing Gao, Shumin Duan, Yue Wang, Zhihua Gao

×

Figure 6

Activation of mTOR is required for NPY induction in DRG neurons after SNI.

Options: View larger image (or click on image) Download as PowerPoint
Activation of mTOR is required for NPY induction in DRG neurons after SN...
(A) qPCR of Npy in DRGs after SNI (n = 3–4 mice per time point). (B) NPY staining in DRGs from Mtorfl/fl mice. Scale bar: 100 μm. (C) ATF3 and NPY staining in the ipsilateral DRG from Mtorfl/fl mice at day 7 after SNI. Arrows represent colabeled neurons. Dotted box represents the region of higher magnification. Scale bars: 200 and 50 μm for low- and high-magnifications, respectively. (D) The ratio of NPY+ in ATF3+ neurons in the ipsilateral DRG from Mtorfl/fl mice at day 7 after SNI. (E) NPY and p-S6 staining in DRGs at day 7 after SNI. Arrows represent colabeled neurons. Scale bar: 50 μm. (F) Ratios of p-S6+ in NPY+ neurons or NPY+ in p-S6+ neurons in the ipsilateral DRG from Mtorfl/fl mice at day 7 after SNI. (G) Quantification of NPY+ neurons in Mtorfl/fl and Mtor-cKOAdv mice at day 7 after SNI (n = 3 mice per group). (H) ATF3 staining in the ipsilateral DRG at day 7 after SNI. Scale bar: 50 μm. (I) p-S6 and p-STAT3 staining in DRGs at day 3 after SNI. Scale bar: 50 μm. (J) Mean intensity of p-STAT3+ nucleus in DRGs at day 3 after SNI (n = 34, 71, and 78 cells from at least 3 mice per group). (K and L) NPY staining and quantification in the ipsilateral DRG after administration of Veh or C188-9 (n = 3 mice per group). Scale bar: 25 μm. (M) Schematic diagram showing the distribution of NPY neurons in DRGs. Data are shown as mean ± SEM. *P < 0.05 and ***P < 0.001, by 1-way ANOVA followed by Bonferroni’s post hoc tests (A, G, and J) or 2-tailed unpaired Student’s t test (L). Cont, contralateral; Ipsi, ipsilateral.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts